Background: Major health organizations recommend that physicians discuss the risks and benefits of prostate cancer screening with men before ordering tests. The length of time that health care providers spend discussing prostate cancer screening-related issues with patients has been given little attention. The purpose of this study was to determine the amount of time that primary care physicians (PCP) in the United States reported spending in discussions about prostate cancer screening with patients by selected PCP individual, practice-related, and screening-related factors. Methods: Data were obtained from the 2007-2008 National Survey of Primary Care Physician Practices Regarding Prostate Cancer Screening. We determined whether PCP characteristics were associated with amount of time spent with patients. Results: Results showed that female, African American or other race, and older PCP spend more time (above the median) with patients compared to their referents. Also, more time spent with male patients was more often associated with PCP having practices in urban inner city areas as well as when the screening decision was shared between the PCP and the patient/family. Conclusion: Results from this study offer some insight into the amount of time that PCP report spending with patients in discussing prostate cancer screening-related issues specifically, and confirms the involvement of individual as well as practice-level factors.
Introduction
There is continued disagreement regarding whether men should be routinely screened for prostate cancer using prostate-specific antigen (PSA). [1] [2] [3] However, major medical and public health organizations agree that men should discuss the benefits and risks of prostate cancer screening with their health care provider before screening decisions are made. 1, [4] [5] [6] [7] Although recent studies indicate that health care providers generally discussed prostate cancer screening with patients, 6, 8 there is little information about the content of these discussions, the general amount of time spent in such discussions, and the association of amount of time spent with patients and physician individual, practice-related, and screening-related characteristics.
Primary care physicians (PCP) routinely offer the digital rectal examination and the PSA test. [9] [10] [11] Physicians, rather than their patients, have typically initiated prostate cancer screening discussions 12, 13 and have made decisions about prostate cancer screening for their patients. 12 Han et al (2006) reported that about two-thirds of men reported having prescreening discussions, and almost 75% of those men reported that PSA screening was initiated by their physician. 12 A more recent qualitative study of men aged 40 or older found that some PCP usually discussed prostate cancer screening with their patients and involved them in a shared decision about undergoing screening tests. 8 However, it is less clear how much time physicians have to discuss prostate cancer screening with male patients and who decides whether age-appropriate men should be screened for the disease.
Identified barriers to physician-patient discussions about prostate cancer screening include lack of time and the complexity of the topic, 10 patient comorbidity, 9 and perception by physicians that the health literacy of their patients is too low for such discussions to be of value. 6 Lack of time was cited as a leading barrier to discussions with men. 6, 13 Time allotted to the physician-patient discussion may not be an individual PCP decision but may be affected by high patient volume, 14 type of health insurance compensation, 15 practice setting, 16 organizational policy (such as increased workload incurred by electronic medical records charting), and other constraints imposed by payors. 6 We did not find studies in the literature that addressed the amount of time spent with patients specifically on prostate cancer screening discussions nor the association of amount of time spent with patients by physician individual, practice-related, or prostate cancer screening-related outcomes. In this study, we examined the above associations in a sample of physicians who shared their practices concerning prostate cancer screening in order to assess characteristics associated with spending more time with patients. This study seeks to determine from physicians themselves current practices in prostate cancer-related discussions. Results will help to clarify whether practice or individual PCP factors are important in influencing prostate cancer screening decisions.
Methods
We analyzed data from the 2007-2008 National Survey Primary Care Physicians Practices Regarding Prostate Cancer Screening, a mailed survey of a nationally representative sample of practicing PCP conducted by the Centers for Disease Control and Prevention (CDC). The Institutional Review Board at the CDC and the Office of Management and Budget reviewed and approved this survey. The questionnaire specifically measured PCP reports of attitudes, beliefs, and behaviors related to prostate cancer and prostate cancer screening. See the appendix following this manuscript for a summary of survey items used in this analysis.
The initial physician sample (N = 3000) was selected from the American Medical Association Physician Masterfile of physicians in the United States. The sampling frame consisted of office-based physicians who spent the majority of their time in direct patient care in family practice, general practice, or internal medicine. Eligibility criteria were that, at the time of the survey, physicians must have provided patient care in an outpatient setting, spent at least 8 hours per week on outpatient care at their primary outpatient practice site, provided health maintenance exams or routine checkups to patients at their primary practice site, and provided care for male patients over age 40. Hospitalbased physicians and federal physicians were excluded. Follow-up surveys were mailed up to 3 additional times to nonrespondents. The survey was completed by 1256 physicians, of whom 633 (50.4%) were African-American and 623 (49.6%) were white or of other race/ethnicity. Asian PCP comprised 91.4% (117/128) of the other race category. After adjusting for surveys that were undeliverable or returned as ineligible or deceased, the overall survey response rate was 57% (1256) of the 2219 eligible PCP.
The survey was developed from previous qualitative analyses of data from PCP focus groups and interviews, 17, 18 and from reviews of previous physician surveys. African American PCP were oversampled to provide information about this understudied group.
Analysis
Our analysis was based on survey participants' responses to the following question: "Approximately how much time is usually involved in the discussion?" All questions in the study were related to prostate cancer screening. Primary care physicians were allowed to enter discussion time in minutes. Responses ranged from 0 to 54 minutes with an average of 5.46 minutes (Fig. 1 ). The majority of the reported time spent values were 2-5 minutes in length. Because there were a few extreme values in sample distribution, we chose to use the median (50 th percentile) of the weighted distribution for our analysis (4.33 minutes). Time spent with patients was dichotomized into 0-4.32 minutes = 1 (below the median amount of time spent or less time) and 4.33 minutes and above = 2 (the median time spent and above or more time).
We then assessed the association between these dichotomized responses and 4 PCP individual characteristics (sex [male, female], race [white, African American, other race], and patient/family decide, patient/family decide or mostly decide] and PCP discussion policy about screening [neutral or discourage screening, encourage screening]).
To account for the survey's stratified sampling design in our analyses of the data, we used SAS, version 9.2 with callable SUDAAN (SAS Institute, Cary, NC [2008]) for final sample weights to generate population-based estimates. We also used chi-square tests to compare the percentages of physicians who spent the median amount of time or above in screening discussions with their patients by various PCP and practice-related characteristics and multivariate logistic regression to estimate the adjusted odds that physicians spent more time with their patients. Only characteristics for which P values from chi-square tests in bivariate analyses were < .20 were retained in the multivariate logistic regression model. All tests were 2-sided, with a significance level of .05.
Results
The PCP weighted sample, representing 95 227 PCP, is shown in Table 1 (column 1). The sample was mostly male (70%) and white (75%). Sixty one percent were general and family medicine practitioners, 43% had suburban practices, and about 42% practiced in a single specialty group. More than half (54%) of PCP reported that decisions to screen for prostate cancer were made jointly between the PCP and the patient/family, whereas 64% reported a policy of encouraging screening.
About 58% of all PCP reported to have spent more time (the median of 4.33 minutes and above) with their male patients ( Table 1 , column 2). There was a significant relationship between sex, race, and age and the amount of time PCPs spent with their male patients. Comparing the weighted percentages across categories of time spent, characteristics of PCP who spent more time with patients included being female, African American or other race, and older age. Also, there was a significant relationship between practice location and who decided whether the patient should be screened. other race, and older age. Primary care practitioners located in suburban and urban inner city areas, as well as those PCP who reported sharing in the screening decision with patients, reported spending more time with patients. The converse was true for those PCPs who spent less time with their patients ( Table 1 , column 3), that is, being male, white, younger age, located in an urban non-inner city area was associated with spending less than the median time in discussion, as was having the screening decision made by the PCP alone or jointly with family.
The multivariate model contained variables that were significant in the bivariate analysis (Table 2, column 1). Female sex, African American or other race, older PCP, PCP in urban inner-city practice locations, and PCP who shared the decision to be screened with men/family had higher odds than their referents of spending more time with their male patients discussing prostate cancer screening. The converse was also true (i.e., all of the above had lower odds compared to their referents) for spending less time with their male patients discussing prostate cancer screening ( 
Discussion
This study found that some PCP reported spending more time with male patients in prostate cancer screening discussions than others and that spending more time varied by individual, practice-related, and screening decision-related factors. Of course, time spent with patients may vary by factors external to PCP themselves, such as organizational constraints, scheduling, and other issues that may dictate how much time is spent with a given patient.
We did not find other studies that examined amount of time spent with the patient specifically in prostate screening discussion in the context of a health maintenance examination. Discussions about more pressing issues such as other chronic disease management and comorbidities may take up much of the PCP-patient discussion time. In one study, patient visits averaged a total of about 15 minutes for all concerns, not just for prostate cancer and other screeningrelated issues. 19 A more recent study between physicians and patients also showed a median overall visit length of 15.7 minutes that covered a median of 6 topics, with the longest topic discussed about 5 minutes, 20 however, the longest topic stated in that study was not mentioned by name. Our finding that the median prostate cancer screening-related discussion lasted slightly less than 5 minutes was similar to the longest topic length in the above study.
Points of interest in this study are that spending time with patients in discussions about prostate cancer was not related to whether the PCP usually recommended (or did not recommend) screening and that time spent was related to the PCP and patient sharing jointly in the decision to be screened. Cooper et al (2004) found that in general, nonscreeners (PCP who did not offer routine screening but discussed the benefits and risks of screening) spent more time in discussions with patients than those who recommended screening. 17 Our study found that there was no association between those who had a usual policy to encourage screening nor those who were more neutral or discouraged screening.
This study offers information about PCP characteristics and their interactions with men. Female, African American or other race, and older PCP reported spending more time with patients discussing prostate cancer screening than male, white, and younger PCP. Stroud et al (2006) found that African American PCP were highly concerned about prostate cancer, 18 especially in their African American male patients who have a higher risk for this disease than patients in other groups. 2 African American PCP in our study may have been highly concerned about this disease, and this level of concern concern may have contributed to the observed length of time spent in screening discussions.
It is interesting to note that compared to white PCP, the other race group (primarily Asian PCP) spent more time in discussions about prostate cancer. This is new information about this group that warrants further study. In addition, PCP in practices located in urban inner cities reported having spent more time with patients discussing prostate cancer screening than their rural counterparts. Perhaps the shortage of PCP in rural areas, 21 as well as the higher percentages of African American and other minority men residing in inner cities, may contribute to this pattern.
This study reveals several new findings about PCP discussions about prostate cancer screening. A new finding is that female PCP reported spending more time than male PCP with male patients in prostate cancer discussions. The pattern of female PCP being more likely than males to be involved in such discussions about prevention practices has been noted, 22 although the amount of time spent with men was not measured. A second important finding related to prostate cancer screening is the finding that the majority of PCP report deciding jointly with the patient and family members whether to be screened. Past studies have found that PCP either mainly made the decision to screen 10 or strongly advised men to undergo screening. 9 Primary care practitioner advice or recommendation was a powerful factor in influencing men to screen for prostate cancer, 11 however, our data show that PCP report more collaborative decision making. This study used data from a comprehensive survey of prostate cancer screening practices among PCP in the United States. It was able to go a step further than earlier qualitative studies 17, 18 to answer more specific questions about self-reported PCP practices regarding prostate cancer screening. Also, data collection and analysis provided weighted estimates that contributed to increased generalizability to the national population of office-based PCP. This study also had limitations, including the reliance on nonvalidated data derived from the self-reports of PCP. 23, 24 A recent study indicated that physicians often over-estimate their time on a given task 25 , however in this study PCP selection was based on conducting several health maintenance examinations weekly, which may allow for better recall on the average amount of time spent on discussions with men. Finally, there is the potential for nonresponse bias. We could not ascertain whether those PCP who participated in the survey and gave information about time spent with patients differed from those PCP who chose not to participate.
Our results suggest that a dialog is taking place between men and their providers concerning prostate cancer screening. Perhaps relevant questions are being posed and answered, and decisions about prostate cancer screening may be shared to some extent, as recommended by several organizations, including the American Cancer Society 2 and the US Preventive Services Task Force (USPSTF). 1, 7 Our data do not allow us to examine whether spending more time with male patients in discussions about prostate cancer screening led to more or less prostate cancer screening after these discussions.
Study findings suggest that we should delve deeper into multiple factors (individual and practice-and screeningrelated) when examining PCP practices and behaviors. This study describes factors associated with PCP spending more time in prostate cancer screening discussions with patients. Future studies are needed to determine if more time spent in discussions by PCPs result in screening decisions that reflect the policy of the physician. In addition, analysis from the current data may also serve as a guide to provide direction for future studies such as an examination of African American and Asian PCP practices, groups that have been understudied in the literature.
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